Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.425 CAD | -1.16% | -4.49% | 0.00% |
Apr. 10 | Spectral Medical Updated on Tigris Trial | MT |
Apr. 10 | Spectral Medical Brief: Providing Tigris Trial Update; 101 patients enrolled | MT |
Sales 2024 * | 1.4M 1.02M | Sales 2025 * | 2.5M 1.82M | Capitalization | 120M 87.64M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 85.8 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 48.1 x |
P/E ratio 2024 * |
-10.8
x | P/E ratio 2025 * |
-21.5
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.49% |
Latest transcript on Spectral Medical Inc.
1 day | -2.27% | ||
1 week | -6.52% | ||
Current month | -8.51% | ||
1 month | -10.42% | ||
3 months | -14.00% | ||
6 months | +36.51% | ||
Current year | +1.18% |
Managers | Title | Age | Since |
---|---|---|---|
Chris Seto
CEO | Chief Executive Officer | - | 19-08-01 |
Paul Walker
CHM | Chairman | - | 01-03-31 |
John Kellum
CTO | Chief Tech/Sci/R&D Officer | - | 21-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Walker
CHM | Chairman | - | 01-03-31 |
Anthony Bihl
BRD | Director/Board Member | 67 | 08-02-29 |
Janelle D'Alvise
BRD | Director/Board Member | 69 | 21-11-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 0.425 | -1.16% | 10 068 |
24-04-22 | 0.43 | -2.27% | 14,910 |
24-04-19 | 0.44 | 0.00% | 32,690 |
24-04-18 | 0.44 | 0.00% | 500 |
24-04-17 | 0.44 | -1.12% | 19,520 |
Delayed Quote Toronto S.E., April 22, 2024 at 02:14 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.18% | 87.52M | |
+25.46% | 659B | |
+26.70% | 557B | |
-4.86% | 359B | |
+16.44% | 322B | |
+8.34% | 297B | |
+6.36% | 215B | |
+7.27% | 210B | |
-6.30% | 200B | |
-8.79% | 149B |
- Stock Market
- Equities
- EDT Stock